Outcomes of Patients With Heart Failure Hospitalized in an Internal Medicine Unit

Outcomes of Patients With Heart Failure Hospitalized in an Internal Medicine Unit - a Four Years Follow-up Study

In 2018, the investigators evaluated the treatment of 236 patients with heart failure (with preserved or reduced ejection fraction) before and after hospitalization in our internal medicine unit (from 2016 to 2017).

The investigators showed that patients, mainly elderly women with comorbidities, often had suboptimal heart failure treatment without an identified cause. The investigators tried, whenever possible, to optimize treatment before hospital discharge.

Our objective is now to analyze the 4-year outcome of these patients, including re-hospitalization for heart failure or death.

Study Overview

• Status: Completed
• Conditions: Heart Failure

• Study Type: Observational
• Enrollment (Actual): 236

Contacts and Locations

Study Locations

• France
  • Montpellier, France, 34295
    • University hospital of Montpellier

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 100 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Patients hospitalized for heart failure or with known heart failure in our Internal Medecine unit between 2016/01/01 and 2018/01/01.

Description

Inclusion criteria:

- Patients hospitalized in our Internal Medecine unit for acute heart failure or for another cause but with known chronic heart Failure

Exclusion criteria:

- Hemodilaysis, end stage kidney disease, heart failure cause by anuria, heart transplantation

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
re-hospitalization for heart failure or death failure assessed by spirometry	re-hospitalization for heart failure or death (yes or no) (composite outcome)	1 day

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
time to re-hospitalization	time to re-hospitalization	1 day
time to death	time to death	1 day
cause of hospitalization	cause of hospitalization	1 day
cause of death	cause of death	1 day

Collaborators and Investigators

• Sponsor: University Hospital, Montpellier
• Investigators: Study Director: Pierre Fesler, PUPH, UH Montpellier

Study record dates

Study Major Dates

• Study Start (Actual): March 1, 2021
• Primary Completion (Actual): April 1, 2021
• Study Completion (Actual): December 25, 2021

Study Registration Dates

• First Submitted: April 13, 2021
• First Submitted That Met QC Criteria: April 13, 2021
• First Posted (Actual): April 14, 2021

Study Record Updates

• Last Update Posted (Actual): April 14, 2022
• Last Update Submitted That Met QC Criteria: April 13, 2022
• Last Verified: April 1, 2022

More Information

Terms related to this study

• Keywords: quality of life; Outcomes; Internal medecine; Heart failure treatment; Heart failure guidelines
• Additional Relevant MeSH Terms: Heart Diseases; Cardiovascular Diseases; Heart Failure
• Other Study ID Numbers: RECHMPL21_0188

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Undecided
• IPD Plan Description: NC

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No